Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - chlorpromazine hydrochloride, quantity: 5 mg/ml - oral liquid - excipient ingredients: sucrose; caramel; peppermint oil; spearmint oil; polysorbate 20; purified water; citric acid; sodium citrate dihydrate; ascorbic acid; sodium sulfite; sodium metabisulfite; sodium benzoate; flavour - 1. treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. long-term treatment of schizophrenia. 3. short-term treatment of agitation and severe depression. 4. severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. in the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. control of intractable hiccough.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - morphine hydrochloride trihydrate, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: sodium citrate dihydrate; citric acid; sodium methyl hydroxybenzoate; glycerol; water for injections; disodium edetate - ordine oral solution is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Ireland - English - HPRA (Health Products Regulatory Authority)

floris holding bv - acepromazine maleate - oral gel - acepromazine

Canada - English - Health Canada

mylan pharmaceuticals ulc - chlorpromazine hydrochloride - liquid - 25mg - chlorpromazine hydrochloride 25mg - phenothiazines

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - morphine hydrochloride trihydrate, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: citric acid; water for injections; sodium methyl hydroxybenzoate; disodium edetate; glycerol; sodium citrate dihydrate - ordine oral solution is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - morphine hydrochloride trihydrate, quantity: 2 mg/ml - oral liquid, solution - excipient ingredients: sodium methyl hydroxybenzoate; glycerol; sodium citrate dihydrate; water for injections; disodium edetate; citric acid - ordine oral solution is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - morphine hydrochloride trihydrate, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: disodium edetate; glycerol; water for injections; sodium methyl hydroxybenzoate; citric acid; sodium citrate dihydrate - ordine oral solution is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - levomepromazine hydrochloride 25 mg/ml equivalent to 22.5 mg/ml levomepromazine base;   - solution for injection - 25 mg/ml - active: levomepromazine hydrochloride 25 mg/ml equivalent to 22.5 mg/ml levomepromazine base   excipient: ascorbic acid sodium chloride sodium sulfite water for injection - nozinan is indicated in the management of terminal pain and accompanying restlessness or distress.

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - escitalopram oxalate, quantity: 25.551 mg/ml (equivalent: escitalopram, qty 20 mg/ml) - oral liquid, solution - excipient ingredients: sodium hydroxide; ethanol; purified water; propyl gallate; citric acid - treatment of major depression. treatment of social anxiety disorder (social phobia). treatment of generalised anxiety disorder. treatment of obsessive-compulsive disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 0.48 mg/ml (equivalent: salbutamol, qty 0.4 mg/ml) - oral liquid - excipient ingredients: sodium benzoate; hypromellose; citric acid monohydrate; sodium chloride; purified water; sodium citrate dihydrate; saccharin sodium; flavour - indications as at 14 february 2005: ventolin is indicated for the prevention and relief of bronchospasm in bronchial asthma of all types and for the alleviation of any reversible airways obstruction associated with conditions such as chronic bronchitis or emphysema.